重度三尖瓣反流合并充血性心力衰竭患者的结局
该回顾性观察研究纳入克利夫兰诊所超声心动图数据库中2556例重度三尖瓣反流(TR)患者,排除心脏移植或无充血性心力衰竭(CHF)者,最终分析534例重度TR合并CHF患者。仅55例(10.3%)接受三尖瓣手术(TVS),非手术患者中30%存在可识别的手术指征。38个月时TVS组生存率优于药物治疗组(62% vs 35%,p<0.001),多因素分析显示TVS与较低死亡率相关(HR: 0.44;95% CI 0.27 to 0.71)。
要点
- 重度TR合并CHF患者中仅10.3%接受TVS,非手术者30%有手术指征。
- 38个月时TVS组生存率62%,药物治疗组35%(p<0.001)。
- TVS与较低死亡率独立相关(HR: 0.44;95% CI 0.27 to 0.71),需随机研究验证。
核心结论
- 矫正性TVS与重度TR合并CHF患者更好的结局相关,但大量患者仍仅接受药物治疗。
研究设计与样本
- 回顾性观察研究,纳入克利夫兰诊所超声心动图数据库2556例连续重度TR患者,排除心脏移植或无CHF者,最终分析534例重度TR合并CHF患者。
主要发现
- 534例重度TR合并CHF患者中仅55例(10.3%)接受TVS;非手术患者479例中143例(30%)有可识别的手术指征。
- 38个月时TVS组生存率62%,药物治疗组35%(p<0.001)。
- 多因素分析显示,年龄每增加10岁死亡风险升高(HR: 1.23;95% CI 1.12 to 1.35),中度右心室功能障碍(HR: 1.39;95% CI 1.01 to 1.90)和重度右心室功能障碍(HR: 2;95% CI 1.40 to 2.80)与较高死亡率相关。
- TVS与较低死亡率相关(HR: 0.44;95% CI 0.27 to 0.71)。
临床怎么用
- 对重度TR合并CHF患者,应考虑评估三尖瓣手术指征,但需注意本研究为观察性设计,不能确定未转诊手术的原因。
局限性
- 无法确定患者未转诊手术的原因,需进一步随机研究验证 findings 后临床方可考虑手术转诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: A substantial number of patients with severe tricuspid regurgitation (TR) and congestive heart failure (CHF) are medically managed without undergoing corrective surgery. We sought to assess the characteristics and outcomes of CHF patients who underwent tricuspid valve surgery (TVS), compared with those who did not. METHODS: Retrospective observational study involving 2556 consecutive patients with severe TR from the Cleveland Clinic Echocardiographic Database. Cardiac transplant patients or those without CHF were excluded. Survival difference between patients who were medically managed versus those who underwent TVS was compared using Kaplan-Meier survival curves. Multivariate analysis was performed to identify variables associated with poor outcomes. RESULTS: Among a total of 534 patients with severe TR and CHF, only 55 (10.3%) patients underwent TVS. Among the non-surgical patients (n=479), 30% (n=143) had an identifiable indication for TVS. At 38 months, patients who underwent TVS had better survival than those who were medically managed (62% vs 35%; p<0.001). On multivariate analysis, advancing age (HR: 1.23; 95% CI 1.12 to 1.35 per 10-year increase in age), moderate (HR: 1.39; 95% CI 1.01 to 1.90) and severe (HR: 2; 95% CI 1.40 to 2.80) right ventricular dysfunction were associated with higher mortality. TVS was associated with lower mortality (HR: 0.44; 95% CI 0.27 to 0.71). CONCLUSION: Although corrective TVS is associated with better outcomes in patients with severe TR and CHF, a substantial number of them continue to be medically managed. However, since the reasons for patients not being referred to surgery could not be ascertained, further randomised studies are needed to validate our findings before clinicians can consider surgical referral for these patients.
引用
- Kadri AN, Menon V, Sammour YM, et al. Outcomes of patients with severe tricuspid regurgitation and congestive heart failure. Heart. 2019. PMID: 31422359. doi:10.1136/heartjnl-2019-315004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。